Trial · NCT04456296
Results by group21
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 20 of 21
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Change From Baseline in 24-Hour Average Systolic Ambulatory Blood Pressure to End of Study (EOS) | AVEED® (Testosterone Undecanoate Injection) | 2.77 | 95% Confidence Interval 0.95 to 4.59 | millimeters of mercury (mmHg) | |
| Change From Baseline in 24-Hour Average Systolic Ambulatory Blood Pressure to End of Study (EOS) | FORTESTA® (Testosterone Gel) | 2.78 | 95% Confidence Interval 0.86 to 4.69 | millimeters of mercury (mmHg) | |
| Change From Baseline in 24-Hour Average Systolic Ambulatory Blood Pressure to End of Study (EOS) | TESTIM® (Testosterone Gel) | 2.15 | 95% Confidence Interval 0.28 to 4.03 | millimeters of mercury (mmHg) | |
| Change From Baseline in 24-Hour Average Mean Arterial Pressure (MAP) to EOS | AVEED® (Testosterone Undecanoate Injection) | 2.13 | 95% Confidence Interval 0.89 to 3.37 | mmHg | |
| Change From Baseline in 24-Hour Average Mean Arterial Pressure (MAP) to EOS | FORTESTA® (Testosterone Gel) | 1.78 | 95% Confidence Interval 0.47 to 3.08 | mmHg | |
| Change From Baseline in 24-Hour Average Mean Arterial Pressure (MAP) to EOS | TESTIM® (Testosterone Gel) | 1.21 | 95% Confidence Interval -0.06 to 2.49 | mmHg | |
| Change From Baseline in 24-Hour Average Diastolic Ambulatory Blood Pressure to EOS | AVEED® (Testosterone Undecanoate Injection) | 1.85 | 95% Confidence Interval 0.79 to 2.91 | mmHg | |
| Change From Baseline in 24-Hour Average Diastolic Ambulatory Blood Pressure to EOS | FORTESTA® (Testosterone Gel) | 1.22 | 95% Confidence Interval 0.10 to 2.34 | mmHg | |
| Change From Baseline in 24-Hour Average Diastolic Ambulatory Blood Pressure to EOS | TESTIM® (Testosterone Gel) | 0.81 | 95% Confidence Interval -0.28 to 1.91 | mmHg | |
| Change From Baseline in 24-Hour Average Heart Rate to EOS | AVEED® (Testosterone Undecanoate Injection) | 2.89 | 95% Confidence Interval 1.47 to 4.31 | beats per minute | |
| Change From Baseline in 24-Hour Average Heart Rate to EOS | FORTESTA® (Testosterone Gel) | 1.56 | 95% Confidence Interval 0.07 to 3.06 | beats per minute | |
| Change From Baseline in 24-Hour Average Heart Rate to EOS | TESTIM® (Testosterone Gel) | 1.84 | 95% Confidence Interval 0.37 to 3.31 | beats per minute | |
| Change From Baseline in 24-Hour Average Pulse Pressure (PP) to EOS | AVEED® (Testosterone Undecanoate Injection) | 0.80 | 95% Confidence Interval -0.41 to 2.0 | mmHg | |
| Change From Baseline in 24-Hour Average Pulse Pressure (PP) to EOS | FORTESTA® (Testosterone Gel) | 1.49 | 95% Confidence Interval 0.22 to 2.75 | mmHg | |
| Change From Baseline in 24-Hour Average Pulse Pressure (PP) to EOS | TESTIM® (Testosterone Gel) | 1.40 | 95% Confidence Interval 0.16 to 2.63 | mmHg | |
| Percentage of Participants Taking New Antihypertensive Medications | AVEED® (Testosterone Undecanoate Injection) | 1.4 | Percentage of participants | ||
| Percentage of Participants Taking New Antihypertensive Medications | FORTESTA® (Testosterone Gel) | 1.5 | Percentage of participants | ||
| Percentage of Participants Taking New Antihypertensive Medications | TESTIM® (Testosterone Gel) | 2.2 | Percentage of participants | ||
| Percentage of Participants With Dose Increase From Baseline in Antihypertensive Medications | AVEED® (Testosterone Undecanoate Injection) | 0 | Percentage of participants | ||
| Percentage of Participants With Dose Increase From Baseline in Antihypertensive Medications | FORTESTA® (Testosterone Gel) | 0 | Percentage of participants |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT04456296/results